ClearPoint Neuro (NASDAQ: CLPT) revenue
ClearPoint Neuro reported revenue of $37.0m for fiscal 2025, 17.8% more than in fiscal 2024 ($31.4m). Since fiscal 2016 its revenue has grown by 543.0%, an average growth of 23.0% a year.
ClearPoint Neuro has grown its revenue for 7 years in a row, and fiscal 2025 is the highest of its 10 fiscal years on record. The biggest drop was in fiscal 2018, −0.4%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $37.0m | +17.8% | −$24.2m | −65.4% |
| 2024 | $31.4m | +31.0% | −$19.7m | −62.9% |
| 2023 | $24.0m | +16.6% | −$22.4m | −93.7% |
| 2022 | $20.6m | +26.1% | −$16.3m | −79.5% |
| 2021 | $16.3m | +27.0% | −$13.4m | −82.1% |
| 2020 | $12.8m | +14.4% | −$6.2m | −48.5% |
| 2019 | $11.2m | +52.5% | −$4.6m | −41.0% |
| 2018 | $7.4m | −0.4% | −$5.2m | −71.4% |
| 2017 | $7.4m | +28.4% | −$6.3m | −85.9% |
| 2016 | $5.7m | — | −$7.5m | −130.3% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
ClearPoint Neuro revenue compared with its sector
By revenue for its latest fiscal year, ClearPoint Neuro ranks 342nd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; ClearPoint Neuro, 17.8%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 340th | Kymera Therapeutics | $39.2m | −16.7% |
| 341st | Utah Medical Products | $38.5m | −5.8% |
| 342nd | ClearPoint Neuro | $37.0m | 17.8% |
| 343rd | C4 Therapeutics | $35.9m | 1.0% |
| 344th | Senseonics | $35.3m | 56.9% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of ClearPoint Neuro
- How much revenue did ClearPoint Neuro make in fiscal 2025?
- ClearPoint Neuro reported revenue of $37.0m for fiscal 2025, compared with $31.4m in fiscal 2024.
- How much has the revenue of ClearPoint Neuro grown?
- Between fiscal 2016 and fiscal 2025 it went from $5.7m to $37.0m: 543.0% more, an average growth of 23.0% a year.
- What was the best year for revenue at ClearPoint Neuro?
- Of its last 10 fiscal years, fiscal 2025, with $37.0m.
- Where does ClearPoint Neuro rank in its sector by revenue?
- It ranks 342nd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for ClearPoint Neuro come from?
- From the annual report (Form 10-K) that ClearPoint Neuro files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that ClearPoint Neuro files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on ClearPoint Neuro: the ClearPoint Neuro page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.